Page last updated: 2024-09-05

sorafenib and 5,7-dimethoxyflavone

sorafenib has been researched along with 5,7-dimethoxyflavone in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(5,7-dimethoxyflavone)
Trials
(5,7-dimethoxyflavone)
Recent Studies (post-2010) (5,7-dimethoxyflavone)
6,5207305,25164038

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)5,7-dimethoxyflavone (IC50)
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)9.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, G; Bae, S; D'Cunha, R; Shao, J1

Other Studies

1 other study(ies) available for sorafenib and 5,7-dimethoxyflavone

ArticleYear
Effect of 5,7-dimethoxyflavone on Bcrp1-mediated transport of sorafenib in vitro and in vivo in mice.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, May-30, Volume: 117

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Dogs; Drug Interactions; Drug Resistance, Neoplasm; Flavonoids; LLC-PK1 Cells; Madin Darby Canine Kidney Cells; Male; Mice; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Swine; Tissue Distribution

2018